Les tumeurs stromales gastro-intestinales (GIST) sont les tumeurs mésenchymateuses les plus fréquentes du système digestif. Elles ont pour origine les cellules interstitielles de Cajal (ICC) ou les cellules précurseurs mésenchymateuses communes aux ICCs et aux cellules musculaires lisses (SMC). Les GISTs sont des tumeurs qui sont chimiorésistantes et radiorésistantes. L'identification de mutations activatrices des gènes KIT (75-80%) ou/et PDGFRA (5-10%) a ouvert la voie à un traitement systémique chez les patients GIST sous forme d'Imatinib, un inhibiteur de tyrosine-kinase. Si ce traitement aboutit à une réponse clinique d'amélioration, un certain nombre d'effet secondaire sont néanmoins observés, comme les résistances au traitement. Afin d'améliorer le traitement initial, la physiopathologie du GIST doit progresser. La musculature de l'appareil digestif est une structure complexe composée de SMCs, de neurones entériques, de fibroblastes et d'ICCs. Au cours du développement, le mésoderme splanchnique donnera lieu au moins à deux types de cellules, les SMCs et les ICCs. Récemment, notre laboratoire a montré que la protéine de liaison à l'ARN RBPMS2 (pour RNA Binding Protein with Multiple Splicing 2) est impliquée dans le développement et le remodelage des SMCs digestives. Les travaux que j'ai réalisés au cours de ma thèse avaient pour objectifs d'étudier l'expression et la fonction de RBPMS2 dans les tumeurs GISTs humains. Nous avons analysé l'expression de RBPMS2 dans les GIST humains et nous avons démontré que RBPMS2 était fortement exprimé dans les tumeurs GISTs de manière indépendante de l'activité KIT. Nous avons également analysé la fonction de RBPMS2 en culture et avons montré que l'expression ectopique de RBPMS2 dans les SMCs humaines adultes et différenciées culture conduisaient à l'augmentation de leur taux de prolifération et altèreraient leur différenciation. Ces résultats suggèrent que RBPMS2 et les voies de signalisation qu´il contrôle pourraient être des cibles thérapeutiques potentielles dans la thérapie des tumeurs GISTs. / Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasm of the GI tract. They are supposed to arise from the interstitial cells of Cajal (ICCs) or from a mesenchymal precursor cell, common of ICCs and smooth muscle cells (SMCs). GISTs are highly resistant to conventional chemotherapy and radiotherapy. However, a targeted therapy is now proposed. These tumors have activating mutations in two closely related genes, the KIT (75-80%) or/and the PDGFRA (5-10%). Targeting these mutated activated proteins with Imatinib mesylate, a small-molecule tyrosine kinase inhibitor, has proven efficient in GIST treatment. However, resistance to Imatinib finally develops and new-targeted therapies are necessary. The musculature of the gastrointestinal (GI) tract is a highly complex structure composed of visceral SMCs, enteric neurons, fibroblast-like cells and ICCs. During the development, the splanchnic mesoderm will give rise at least to two cell types, ICCs and SMCs. Recently our laboratory showed that the RNA Binding Protein with Multiple Splicing 2 (RBPMS2) is involved into the development and remodeling of SMC.My PhD works investigate the expression and function of RBPMS2 in human GISTs. We analyzed the expression of RBPMS2 in human GISTs and we found that RBPMS2 was abnormally highly expressed in the tumoral cells of GISTs. We also analyzed the function of RBPMS2 into human adult SMC cell culture and demonstrated that ectopic expression of RBPMS2 in mature and differentiated SMC cultures increases their proliferation rate and alters their differentiation. These findings suggest that RBPMS2 could be a potential target for cancer therapy.

Les papillomavirus humains (HPV) sont des virus à ADN double brin qui infectent la peau et les muqueuses. Les infections par les HPV, bien que majoritairement asymptomatique, provoquent des défauts de prolifération cellulaire pouvant parfois générer des cancers. Selon leur pouvoir carcinogène, on distingue les HPV à bas risque oncogène (HPV-BR) provoquant des lésions bénignes, et les HPV à haut risque (HPV-HR) responsables de l’apparition de nombreux cancers ano-génitaux et de certains cancers des voies aéro-digestives supérieures. Parmi les HPV-HR, HPV16 est le plus prévalent. La carcinogenèse induite par les HPV-HR est corrélée à l’expression des protéines virales E6 et E7, qui dérégulent de nombreux processus cellulaires. L’expression des gènes viraux, réalisée par la machinerie de la cellule hôte, est finement régulée particulièrement au niveau posttranscriptionnel. En outre, l’épissage alternatif génère une vingtaine de transcrits viraux, permettant l’expression des protéines virales. L’épissage au sein de la région codante E6 permettant de former l’isoforme E6*I est présent uniquement chez les HPV-HR, mais pas chez les HPV-BR, ce qui suggère son implication dans la carcinogenèse induite par les HPV-HR. Toutefois, le rôle biologique de la protéine E6*I produite par les HPV-HR est encore controversé.Afin de mieux appréhender les mécanismes de la carcinogenèse induite par les HPV-HR, nous nous sommes intéressés à : (i) l’étude des fonctions biologiques de l’isoforme E6*I, et (ii) aux mécanismes impliqués dans la régulation de l’expression de E6 et E7.Pour appréhender le rôle biologique d’E6*I d’HPV16, nous avons utilisé le séquençage de l’ARN afin d’identifier des cibles dérégulées par son expression ectopique. L’expression des isoformes E6 et E6*I d’HPV16 dans des cellules HPV négatives dérégule des transcrits impliqués dans des processus biologiques relatifs à l’expression des gènes viraux, la carcinogenèse virale, la transduction du signal et la traduction. L’expression d’E6*I seule, dérégule des transcrits impliqués dans l’organisation de la matrice extracellulaire, des voies de signalisation et d’adhérence cellulaire. De façon intéressante, il a été montré que ces gènes dérégulés par l’expression d’E6*I sont communément affecté par le niveau intracellulaire de ROS (espèces réactives de l’oxygène). Cela corrobore le rôle d’E6*I dans l’augmentation de la production de ROS. Le stress oxydatif associé aux ROS pourrait favoriser l’intégration du génome viral à celui de la cellule hôte, caractéristique de carcinogenèse associée aux HPV-HR. En somme, E6*I pourrait avoir un rôle oncogénique indépendant de celui d’E6, et interviendrait dans la carcinogenèse associée aux HPV-HR.Nous avons aussi étudié le rôle du complexe de jonction des exons (EJC), dans la régulation posttranscriptionnelle de l’expression d’E6 et E7. L’EJC est un complexe multiprotéique déposé sur les ARNm via l’épissage influençant ainsi leur devenir. Nous avons montré qu’un facteur de l’EJC, eukaryotic initiation factor 4A3 (eIF4A3), se liait aux ARNm viraux. Par ailleurs, nous avons observé que les composants de l’EJC affectent, certes de différentes façons, l’expression d’E6 et E7. Enfin, nous avons aussi étudié l’effet du nonsense-mediated mRNA decay (NMD), un mécanisme lié à l’EJC, sur l’expression d’E6 et E7. Non seulement nos résultats suggèrent que le NMD inhibe l’expression d’E6 et E7, mais nous avons aussi observé que la protéine E6 d’HPV16 réduit l’activité du NMD. Cette inhibition permettrait à HPV16 d’avoir un contrôle sur ses transcrits mais d’affecter aussi des cibles cellulaires du NMD. Etant donné l’implication des gènes régulés par le NMD dans le maintien de l’homéostasie et l’adaptation cellulaires, il serait intéressant d’appréhender le rôle de cette nouvelle activité d’E6 dans la carcinogenèse associée aux HPV-HR. / Human papillomaviruses (HPV) are double strand DNA viruses that infect skin and mucosa. HPV infections, although mostly asymptomatic, cause cell proliferation defects that can sometimes give rise to cancer. According to their carcinogenic potential, we distinguish low-risk HPVs (lr-HPV) causing benign lesions, and high-risk HPV (hr-HPV) responsible for the appearance of numerous anogenital and some head and neck squamous-cell cancers. Among the hr-HPV, HPV16 is the most prevalent. Hr-HPV-induced carcinogenesis is correlated with the expression of the viral oncoproteins, E6 and E7, which deregulate many cellular processes. Viral gene expression, performed by the host cell machine, is finely regulated particularly at the post-transcriptional level. Besides, alternative splicing generates about twenty viral transcripts, leading to the expression of viral proteins. The splicing within the E6 open reading frame that generates an E6*I mRNA only in hr-HPV, but not in the lr-HPV, suggests its involvement in hr-HPV-induced carcinogenesis. However, the biological role of E6*I protein produced by HPV-HR is still controversial.In order to better understand the mechanisms of hr-HPV-induced carcinogenesis, we have interested in: (i) the study of the biological functions of the E6*I isoform, and (ii) the mechanisms involved in the regulation of E6 and E7 expression.To get insight the biological role of HPV16 E6*I, we used RNA sequencing to identify targets deregulated by its ectopic expression. Expression of HPV16 E6 and E6*I isoforms in negative HPV cells deregulate several transcripts involved in biological processes related to viral gene expression, viral carcinogenesis, signal transduction and translation. The expression of E6*I alone, deregulates transcripts involved in the organization of the extracellular matrix, signaling pathways and cell adhesion. Interestingly, it was shown that the genes deregulated by E6*I expression are commonly affected by the intracellular level of ROS (reactive oxygen species). These results support the role of E6*I in increasing ROS production. The ROS-associated oxidative stress could favor viral genome integration with that of the host cell, a characteristic of hr-induced carcinogenesis. In sum, E6*I may have an oncogenic role independent of E6, and intervene in the carcinogenesis associated with hr-HPV.We also studied the role of the exon junction complex (EJC) in the posttranscriptional regulation of E6 and E7 expression. EJC is a multiprotein complex deposited on mRNAs via splicing, thus influencing their fate. We have shown that a factor of EJC, eukaryotic initiation factor 4A3 (eIF4A3), binds to viral mRNAs. Moreover, we have observed that the components of the EJC affected, in different ways, the expression of E6 and E7. Finally, we also studied the effect of nonsense-mediated mRNA decay (NMD), a mechanism linked to the EJC, on the expression of E6 and E7. Our results suggest that not only NMD inhibits the expression of E6 and E7, but we have also observed that HPV16 E6 protein reduces NMD activity. This inhibition would allow HPV16 to have control over its transcripts but also to affect NMD cellular targets. Given the involvement of NMD-regulated genes in the maintenance of cellular homeostasis and adaptation, it would be interesting to understand the role of this new E6 activity in carcinogenesis associated with HPV-HR.

Les cellules Natural Killer (NK) sont jouent un rôle essentiel dans la surveillance des hémopathies malignes. Cependant, les cellules tumorales développent des mécanismes immunosuppresseurs pour échapper à l'immunité cellulaire NK. Ainsi, le maintien ou l'amélioration des performances des cellules NK sont considérés comme des défis majeurs. Les objectifs de cette partie étaient d'évaluer l'impact de la perfusion de cellules NK activées sur la récupération et la biologie des cellules NK circulantes après l'allo-SCT. Des doses croissantes de cellules NK activées par IL-2 ex-vivo ont été perfusées chez des patients atteints de tumeurs malignes hématologiques 3 mois après allo-SCT. Nos résultats ont montré une fréquence plus élevée des cellules NK dans la périphérie des patients traités. Bien que le phénotype immature soit remarquable peu après le traitement, les cellules NK circulantes, présentaient un état d'activation avec un profil de maturation amélioré après 6 mois de traitement. Nous avons également constaté que l'expression des récepteurs NK activateurs (NKG2D, NKp30 et NKp46) augmentait sur les cellules NK circulantes des patients. De plus, ces cellules ont montré une augmentation significative de la capacité de dégranulation ainsi que de la sécrétion de cytokines (IFN-Ƴ et TNF-α) tout au long de l'étude. Ces différences ont notamment été observées chez les patients ayant reçu des doses plus importantes de cellules NK activées. En conclusion, nous supposons que la perfusion de fortes doses de cellules NK activées ex-vivo pourrait être associée à l'amélioration du phénotype et des fonctions des cellules NK au cours de la reconstitution immunitaire après allo-SCT. / Natural killer (NK) cells are effector lymphocytes of the innate immune system that have the ability to kill transformed cells. They play a critical role in hematological malignancies surveillance, however, tumor cells develop immunosuppressive mechanisms to escape NK cell-mediated killing. So, maintaining or improving NK cell performance is considered a major challenge. Our goals are to evaluate the impact of activated NK cells infusion on the recovery and biology of circulating NK cells post allo-SCT.Three different doses (dose 1: 106 NK cell/Kg, n=3; dose 2: 5x106 NK cell/Kg, n=7; dose 3: >5x106 NK cell/Kg, n=6) of ex-vivo IL-2 activated NK cells were infused into patients with hematological malignancies after all-SCT. Our results showed higher frequency of NK cells in the periphery of patients treated with larger doses of activated NK cells. Although the notable immature phenotype shortly after treatment, the circulating NK cells in patients receiving larger doses of activated NK cells displayed more activation status with improved maturation profile after 6 months of treatment. We also found that the expression of activating NK receptors (NKG2D, NKp30, and NKp46) augmented on circulating CD56dim NK cells of patients receiving larger doses of activated NK cells. Moreover, these cells showed a significant increase in degranulation capacity as well as cytokine secretion (IFN-Ƴ and TNF-α) throughout study period. In conclusion, we hypothesize that infusion of high-dose of ex-vivo activated NK cells could be associated with improvements of NK cell phenotype and function during immune reconstitution after allo-SCT.

No carcinoma papilífero de tiroide (CPT) ocorrem alterações na via MAPK (do inglês Mitogen-Activated Protein Kinase), sendo a mais frequente mutação a BRAFT1799A. A via MAPK é modulada pelo miRNA, como o let-7 que estão pouco expresso no CPT. A biogênese de let-7 é controlada por proteínas ligantes de RNA LIN28 que inibem o processamento das formas primária e precursora de let-7 (pri-let-7 e pre-let-7). Avaliamos a expressão gênica de LIN28, pri-let-7f, pre-let-7f e let-7f por rtPCR em tempo real, utilizando RNA total das linhagens TPC-1 e BCPAP de PTC e amostras tumorais de pacientes com CPT. A linhagem não tumoral Nthyori 3-1 foi utilizada para induzir LIN28. Observa-se redução de let-7f em 4 dos 5 pacientes analisados enquanto que LIN28A está aumentado em 2 pacientes com BRAFT1799A. Nota-se maior expressão de pri-let-7f em TPC-1 e menor expressão de pre-let-7f e let-7f. Observa-se maior expressão de LIN28A em TPC-1, enquanto que LIN28B está mais expresso em BCPAP com BRAFT1799A. A inibição de BRAFV600E em BCPAP diminui LIN28B e aumenta let-7f, enquanto que a indução de LIN28B reduz a expressão de let-7f. Concluímos que há relação inversa entre LIN28 e let-7f no CPT e LIN28 influencia a diminuição de let-7f podendo assim contribuir com tumorigênese tireoidiana. / In papillary thyroid cancer (PTC) changes in MAPK (Mitogen-Activated Protein Kinase) pathway are common being BRAFT1799A mutation the most frequent alteration. MAPK pathway is modulated by miRNA such as let-7, an under-expressed miRNA in PTC. The RNA binding protein LIN28 controls let-7 biogenesis, blocking primary and precursor let-7 (pri-let-7 e pre-let-7) processing. We evaluated LIN28, pri-let-7f, pre-let-7f and let-7f gene expression by real time RTPCR using total RNA of human PTC sample and PTC cell lines TPC-1 and BCPAP. Non-tumoral cell line Nthyori 3-1 was used to evaluate LIN28B influence in let-7f. We observed decreased let-7f expression in 4 out of 5 PTC patients, and increased LIN28A in 2 patients with BRAFT1799A mutation. TPC-1 cells express higher levels of pri-let-7f while pre-let-7f and let-7f are less expressed. We noted that LIN28A is more expressed in TPC-1, while LIN28B is more expressed in BCPAP cells with BRAFT1799A. The inhibition of BRAFV600E in BCPAP decreases LIN28B and increases let-7f, while the induction of LIN28B in Nthyori 3-1 reduces let-7f expression. We conclude there is an inverse association between LIN28 and let-7f in PTC, and that LIN28 influences let-7f reduction which could contribute to thyroid tumorigenesis.

Oocyte development in Xenopus laevis spans six morphologically distinct stages (stage I-VI), and is associated with a decrease in protein O-GlcNAc levels. As a first step in elucidating the role of O-GlcNAc in developing oocytes, initial efforts were focused on isolation and identification of fifteen modified proteins that decrease during oocyte development. Stage I oocytes due to their high amounts of these proteins, were used as starting material for purification. Multiple affinity and specific antibody based purification technique were initially used in an attempt to enrich the O-GlcNAc proteins. Due to the unique properties of the proteins ultimately identified, these techniques were unable to provide sufficient material for sequencing. However, differential centrifugation coupled with 2D-gel electrophoresis was highly successful. The majority of isolated proteins were strongly basic in nature with pIs 8-10. Coomassie stained bands from 2D-analysis were trypsin digested, and peptides were sequenced by mass spectroscopy (Finnigan LCQ). Mass data were interpreted by Bioworks software, and protein sequences were compared to multiple protein databases. Initially, six proteins were identified as Thesaurin a (42Sp50), cytoplasmic mRNA binding protein p54, y-box homolog, Xp 54 (ATP dependent RNA helicase p54), Vg1 RNA binding protein variant A, Zygote arrest 1(Zar1) and Poly (A) binding protein (PABP). Thesaurin a, the main component of 42S particle of previtellogenic oocytes (stages I-III) is involved in tRNA storage and possess low tRNA transfer activity; y-box factor homolog and Xp54 are present in oocyte mRNA storage ribonucleoprotein particles; Vg1 RBP variant A associates mVg1 RNA to microtubules in order to translocate to the vegetal cortex; Zar1 is involved in oocyte-to-embryo transition; and PABP initiates mRNA translation. This study is the first to characterize these oocyte specific proteins as O-GlcNAc modified proteins. Overall, the presence of several O-GlcNAc proteins in oocytes, the reduction in their levels/ O-GlcNAc levels, and the variation in maturation time in the presence of HBP-flux modulators in developing oocyte indicates O-GlcNAc may play important roles in metabolism, cell growth and cell division of X. laevis oocytes. Therefore, identifying the remainder of these proteins and elucidating the O-GlcNAc role in their function is a worthwhile pursuit.

Die chloroplastidäre Genexpression ist durch charakteristische posttranskriptionelle Ereignisse, wie RNA-Prozessierung, RNA-Stabilität, RNA-Edierung oder RNA-Spleißen gekennzeichnet. Diese Prozesse werden fast ausnahmslos durch kernkodierte Proteine realisiert. PPR-Proteine (Pentatricopeptid repeat) stellen unter diesen kernkodierten Faktoren die größte Proteinfamilie dar. Das plastidäre Protein P67 gehört zur kleinen Untergruppe der PPR-Proteine mit SMR-Domäne (small MutS-related), deren molekulare Funktion im organellären Nukleinsäuremetabolismus bislang unverstanden ist. P67 zeigt eine nahe Verwandtschaft zu GUN1, einem zentralen Bestandteil retrograder Signalwege. Der hier analysierte P67-Knockout in Mais verursacht hellgrüne Phänotypen, eine drastische Reduktion der plastidären ATPase und Keimlingsletalität, was die essentielle Beteiligung von P67 an den Prozessen der Chloroplastenbiogenese und der Expression der plastidär kodierten ATPase-Untereinheiten vermuten lässt. Mögliche Implikationen eines fehlenden Phänotyps von Mutanten des P67-Orthologs aus Arabidopsis thaliana werden diskutiert. Eine Ausnahmestellung unter den Proteinen des chloroplastidären RNA-Metabolismus nimmt der einzige plastidär kodierte RNA-Reifungsfaktor MatK ein. Die genomische Position des matK-Gens im Intron der trnK-UUU ist in allen grünen Landpflanzen konserviert. MatK ist mit bakteriellen Maturasen verwandt, die spezifisch den Spleißprozess ihres Heimatintrons unterstützen. Dagegen deuten genetische und phylogenetische Studien zusätzliche MatK-Funktionen in trans an. In der vorliegenden Arbeit wird die spezifische Interaktion von MatK mit sieben Gruppe-IIA-Intron enthaltenden Transkripten in vivo gezeigt. Darunter befinden sich vier tRNA-Vorläufer (trnK-UUU mit dem matK-Heimatintron sowie trnV-UAC, trnI-GAU, trnA-UGC) und drei proteinkodierende Vorläufertranskripte (rpl2, rps12, atpF). Die Feinkartierung der MatK-Bindung im trnK-Heimatintron zeigt eine Assoziation mit multiplen Regionen. Organelläre Gruppe-II-Introns gelten als Vorläufer der spleißosomalen Introns. Die Assoziation mit multiplen Gruppe-II-Introns macht MatK somit zu einem interessanten Modell für die Evolution der transaktiven Spleißaktivität im Kern. Analysen der Expression von MatK und seinen Zielen deuten auf ein komplexes Muster möglicher regulativer Interaktionen hin. / Chloroplast gene expression is characterized by posttranscriptional events including RNA cleavage, RNA stability, RNA editing, and RNA splicing. The underlying processing machinery is almost exclusively encoded in the nucleus. PPR proteins (pentatricopeptide repeat) form the biggest protein family among these factors and are major players of the aforementioned posttranscriptional processes. The plastidial protein P67 is a member of a small subgroup of PPR proteins with SMR domain (small MutS-related). Molecular functions of this protein family in organellar nucleic acid metabolism are yet unknown. P67 is a close relative of GUN1, an essential component of the chloroplast to nucleus retrograde signalling pathway. It is shown here that a P67 knockout in maize causes pale green phenotypes, a dramatic reduction in ATPase levels, and seedling lethality. This indicates an essential role of P67 for chloroplast biogenesis and expression of the plastid encoded ATPase. The finding that mutants of the P67-orthologe in Arabidopsis lack a phenotype is discussed against the background of physiological differences between maize and Arabidopsis. A special case among proteins involved in plastid RNA metabolism is MatK - the only plastid encoded RNA maturation factor. The genomic position of the matK gene in the trnK-UUU intron is conserved throughout autotrophic land plants. MatK is related to bacterial maturases - highly specific splice factors supporting splice processes of their respective home introns. There is, however, indirect genetic and phylogenetic evidence that MatK acts also in trans as a common plastidial splice factor serving various group II introns. This study shows that MatK interacts specifically with seven group IIA introns in vivo. Among them are four tRNA precursor transcripts (trnK-UUU including the matK home intron as well as trnV-UAC, trnI-GAU, trnA-UGC) and three protein-coding precursors (rpl2, rps12, atpF). Fine mapping of MatK binding sites within the trnK home intron uncovers protein RNA interactions with diverse intron regions. Organellar introns have been suggested as evolutionary ancestors of nuclear spliceosomal introns. Consequently, association of MatK with multiple group II intron ligands makes the plastidial maturase an attractive model for an early trans-acting nuclear splice activity. Analyses of the expression of MatK and its targets revealed a complex pattern of possible regulatory interactions.

Non-protein coding eukaryotic genome sequences often referred to as junk DNA are estimated to encode several non-coding RNAs (ncRNAs) which may account for nearly 98% of all genomic output in humans. The output of such a wide spread transcription in eukaryotes consists of intronic, antisense and small RNAs. In addition to the classical ncRNAs such as rRNA, tRNA and small nucleolar RNAs, the eukaryotic genome encodes two distinct categories of ncRNAs, referred to as small ncRNAs and long mRNA–like ncRNAs (mlncRNAs). The long ncRNAs, which are transcribed by RNA Polymerase II, spliced and polyadenylated, are implicated in a number of regulatory processes such as imprinting, X-chromosome inactivation, DNA demethylation, transcription, RNA interference, chromatin structure dynamics and antisense mediated regulation. Expression of noncoding RNAs is altered during stress conditions and a large number of such transcripts have been identified of late. This study has identified a novel ncRNA whose expression is upregulated during viral infection of mouse brain. While we have named this RNA as VINC or virus inducible ncRNA, others have named it as NEAT1 (Hutchinson et al., 2007) and Men (Sunwoo et al., 2008). VINC/NEAT1/Men is associated with a distinct nuclear domain called paraspeckles Using a cell line as well as an animal model system we have investigated VINC in great detail and based on these studies we report that VINC is a nuclear ncRNA that localizes to paraspeckles and it interacts with the paraspeckle protein, P54nrb in both cell line model system as well as in animal tissues by a combination of in vitro and in vivo methods. We have also mapped the domains within VINC that are involved in P54nrb interactions. Till date, the only other RNA known to localise to paraspeckles is CTN-RNA. While CTN-RNA is a protein coding RNA, VINC does not code for a protein and thus VINC is the first ncRNA to be localized to paraspeckles. Further, the mechanism of nuclear retention of these two paraspeckle RNAs appears to be distinct. In case of CTN-RNA, it has been clearly shown that it is A-I edited and such hyperedited RNAs are retained by the p54/nrb mediated complex in nucleus (Zhang and Carmichael, 2001). However the mechanism by which VINC is retained in nucleus is not clear. There is apparently no A-I editing in VINC and hence VINC retention in the nucleus by binding to nuclear proteins such as p54/nrb might involve a different mechanism. It is well established of late that nuclear matrix retains RNAs and that there is a population of poly (A) RNA that is retained in nucleus (Huang et al.,1994 ; Carter et al.,1991). However the significance of such retention is not clear but it is believed that it might be important for some constitutive functions in nucleus (Nickerson et al., 1989). More investigations are needed to understand the exact functions of nuclear RNAs such as VINC in supporting the nuclear architecture. P54nrb is a multi functional nuclear protein that mediates most of its functions in association with PSF (Shav-Tal and Zipori, 2002). Phosphorylation status of P54nrb is a key determinant for its localisation to various nuclear regions. P54nrb is a multiphosphorylated protein during mitosis and its phosphorylation is mediated by PIN-1 at its C-terminus (Proteau et al., 2005). Tyrosine phosphorylation of P54nrb is essential for it to be retained in nuclear matrix (Otto et al., 2001). The N-terminal phosphorylation is speculated but not much has been investigated. The protein has two distinct RNA recognition motifs (RRMs) in its N-terminus that are responsible for its RNA binding activity. The significance of the p54/nrb-PSF heterodimer cannot be undermined as they have been shown to be important during HIV replication. The dimer is recruited by viral machinery and P54nrb has been shown to be exported to cytosol for binding to replicative complexes (Zolotukhin et al., 2003). During adenoviral replication in nucleus many SR proteins are recruited to viral replication foci and rearrangement of speckle components happen. It has been shown with respect to speckles that nuclear domains are highly dynamic and exchange of proteins depends upon the transcriptional status of cell (Lamond and Spector, 2003). Flaviviral replication complexes are hosted in nucleus and ~20% of this complex docks in nucleus and serves as an alternate site for viral replication. The presence of viral replicative complexes alters the nuclear organisation and hence modulation of gene expression is expected (Uchil et al., 2006). The up regulation of nuclear ncRNA such as VINC is definitively one of those events associated with viral replication and definitively one needs to study the various changes carefully to understand the role of VINC in virus life cycle and/or viral pathogenesis. VINC interaction with the multi-functional nuclear protein P54nrb raises interesting aspects related to function of P54nrb in JEV infection. Knockdown of P54nrb in human myeloid cell line results in abnormal size of paraspeckles and impairs chondrogenesis (Hata et al., 2008). PSF-P54nrb complex can divert many of HIV gag RNA complexes to paraspeckles thus trying to restrict viral replication. However the exact relationship between paraspeckles and its constituent proteins is not clear. The presence of ncRNA adds another new dimension to paraspeckles. It is unclear whether the ncRNA VINC is essential for paraspeckle structure but a recent study indicates that Men (VINC/NEATI) RNA may be essential for paraspeckle formation (Sunwoo et al., 2008). The exact function VINC in neuronal as well as non-neuronal cell nuclei remains elusive and more investigations are need to understand these aspects.

PTB (HnRNP I) is a multifunctional RNA binding protein which participates in a variety of RNA metabolic processes put together called as post transcriptional gene regulation. It interacts with shuttling hnRNPs L, K and E2 of the spliceosomal machinery and also with other RNA binding proteins like PSF, Raver1 and Raver2, which assists PTB in splicing. Based on the complexity of these processes and multifunctional nature of PTB, we hypothesized that; it might interact with various additional proteins not identified till date. Keeping this objective in mind, we set out to screen the custom made 18 day old mouse testes cDNA library in pGAD10 vector available in the laboratory, to hunt for novel interacting partners of PTB using the Clontech’s Matchmaker Gal4 yeast two hybrid system III. PTB1, the prototype of PTB was chosen and the above mentioned cDNA library was screened for novel PTB interacting partners. Twenty five large scale library transformations (spanning 8*106 independent clones) were performed and 99 putatives were obtained. By re-transformation of these library plasmids with bait construct to check for the interaction phenotype and eliminating bait independent activation of reporter genes and elimination of known false positives, only 5 clones were consistent with the interaction phenotype. All these library plasmids were sequenced with vector specific primers, ORF was identified and BLAST analysis for the identification of insert was done. Two of these clones encoded the partial CDS of mouse Protein Inhibitor of Activated STAT3-PIAS3. One of these encoded the partial CDS of mouse TOLL Interacting Protein-TOLLIP. The other two encoded the partial CDS of mouse importin-α and mouse hnRNP K, both of which were already known interacting partners of PTB. GST pull down assay and mammalian matchmaker co-immunoprecipitation was used for confirming the in vitro one to one physical interaction between PTB and these newly identified protein partners. Indirect Immunofloresence was used for demonstrating the co-localization of PTB and PIAS3 in Gc1Spg mouse spermatogonial cell line. The fact that PIAS3 an E3 SUMO ligase was picked up as an interacting partner of PTB was interesting and we hypothesized that PTB might be a sumoylation substrate. Towards this, we first resorted to the prediction of sumoylation consensus motif by using SUMOPLOT. PTB indeed was found to have sumoylation consensus sites. Subsequently, in vivo sumoylation of PTB was demonstrated, where in over expression of donor protein [SUMO-1] and acceptor protein [PTB] in RAG-1 mouse kidney cell line had resulted in the identification of an approximately 67 kDa slow moving SUMO modified myc tagged PTB band apart from the bulk of unmodified 57 kDa myc-PTB. This confirmed the fact that PTB is SUMO modified only at a single consensus target site in vivo and attempts are made to map this site of modification. SUMOylation regulates diverse biological processes in vivo ranging from nucleo- cytoplasmic shuttling, alteration of protein-protein interaction, DNA protein interaction etc. PTB shuttles rapidly between the nucleus and cytoplasm in a transcription sensitive manner and the translocation of PTB to the cytoplasm, happens under the conditions of cell stress, viral infections, apoptosis and exposure of cells to genotoxic agents like doxorubicin. Phosphorylation of PTB at Ser-16 residue has been shown to modulate the nucleo-cytoplasmic shuttling of PTB, albeit shuttling can also occur irrespective of this modification. Interaction of PTB with an E3 SUMO ligase-PIAS3 and the fact that it is SUMOylated in vivo, we hypothesize that K-47 residue present in the NLS/NES might be the most probable site of this SUMO modification and SUMOylation of PTB by PIAS3 might regulate the nucleo-cytoplasmic shuttling of PTB.

Le syndrome de l’X fragile représente la première cause de déficience intellectuelle héréditaire. Ce syndrome résulte de l’absence de la protéine FMRP. FMRP est proposée réguler, sous contrôles des mGluR-I et d’autres récepteurs, l’expression de protéines importantes pour la plasticité synaptique en se fixant spécifiquement sur leur ARNm et en modulant leur traduction. Des milliers d’ARNm cibles ont déjà été proposées dans la littérature, mais très peu ont pu être validées. Par approche de pontage covalent aux UV et immunoprecipitation (CLIP) couplé à une analyse microarray, nous avons identifié un ARNm comme cible unique de FMRP dans les neurones corticaux. Cet ARNm code pour une kinase contrôlant le niveau de deux seconds messagers lipidiques importants pour le remodelage des épines dendritiques. De plus, nous avons montré que l’activation mGluR-I dépendante de la kinase est absente dans les neurones Fmr1 KO, avec pour conséquence une altération de plusieurs espèces lipidiques du neurone. Ces défauts peuvent expliquer les altérations morphologiques et fonctionnelles des épines dendritiques, cause principale proposée du syndrome de l’X fragile. / Fragile X syndrome is the leading cause of inherited intellectual disability and is due to the absence of the RNA binding protein FMRP (Fragile X Mental Retardation Protein). FMRP is proposed to bind and regulate synaptic expression of mRNA targets upon mGluR-I activation. Thousands of mRNA targets have already been proposed in the literature, but only a few have been validated leaving unsolved the question of the genes mostly affected by the absence of FMRP in the brain of fragile Xpatients. The main project of the thesis was to identify the mRNAs associated with FMRP in cortical neurons by performing cross-linking immunoprecipitation approach (CLIP). We found that FMRP principally targets one unique mRNA which encodes an important synaptic kinase. This enzyme controls the level of two second lipid messengers important for remodeling of dendritic spines. Consequently, the mGluR-I-dependant activation of the enzyme is lost in absence of FMRP, leading to several lipid species alterations in the neuron. These defects may explain the morphological and functional alterations of dendritic spines, the hallmark of fragile X syndrome.

Dans les cellules eucaryotes, l'expression des gènes est régulée à de multiples étapes. Les régulations post-transcriptionnelles regroupent l'ensemble des contrôles qui s'exercent sur un ARN, en particulier sa maturation nucléaire, sa stabilité et son contrôle traductionnel. Les protéines de liaison aux ARN sont des acteurs majeurs de ces régulations post-transcriptionnelles. Les protéines CELF1 et ELAVL1, abondantes et quasiment ubiquitaires, participent à ces différents niveaux de régulation et sont susceptibles de modifier le devenir des transcrits. Au cours de ces travaux, nous avons étudié l'impact de CELF1 sur l'abondance et la maturation des ARN par des approches transcriptomiques. Nous avons classé les transcrits en fonction de leurs réponses aux différentes inactivations. L'ensemble de ces données montre que i) CELF1 et ELAVL1 ont des rôles bivalents, leur déplétion étant associée à une répression ou une activation de certains gènes ; ii) dans des cellules HeLa, les effets des différentes déplétions sont majoritairement des effets indirects ; iii) CELF1 et ELAVL1 ont très majoritairement le même effet sur l'abondance des ARNm qu'elles contrôlent directement ; iv) CELF1 et ELAVL1 ont le plus souvent des effets coopératifs ou redondants sur l'abondance des transcrits liés. L'effet combinatoire de CELF1 et ELAVL1 dépend de l'ARNm considéré, révélant une complexité des régulations post-transcriptionnelles critiques pour le devenir d'une cellule. / In eukaryotic cells, after transcription gene expression is controlled at multiple steps. These qualitative and quantitative post-transcriptional regulations are specified by RNA binding proteins (RBP). By combining transcriptomic analysis and binding site information for CELF1, we showed that CELF1 regulates both nuclear and cytoplasmic steps of gene expression. CELF1 directly controls the stability of cyclin D1 mRNA and the splicing of several RNA including KLC1 (light chain kinesin 1). Because mRNAs are in complexes consisting of multiple RBP we studied whether CELF1 and ELAVL1 would interact and control the abundance of their bound mRNAs. This analysis unravel a surprising redundancy or cooperativity of CELF1 and ELAVL1. The combinatorial effects of CELF1 and ELAVL1 were highly dependent on the considered RNA. Interestingly, we showed that both proteins cooperate and interact physically.